Highlighted Article in ELSEVIER Antiviral Research March 2022 Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method. Verrier ER, Salvetti A, Pons C, Michelet M, Rivoire M, Baumert TF, Durantel D, Lucifora J.Antiviral Res. 2022 Feb;198:105250....
ERC-PoC-Grant CANDY Press Release
Press Release Strasbourg, February 7th, 2021 ERC PROOF OF CONCEPT 2022 CANDY “THERAPEUTIC DISCOVERY FOR CHOLANGIOCARCINOMA” Prof. Thomas Baumert, MD is a laureate of the prestigious ERC Proof of Concept Grant for the third time in five years. The ERC Proof of Concept CANDY program will focus on developing novel...
PhD Call 2022 is open!
PhD Call 2022 is open! This interdisciplinary program, funded by the PIA program from the French National Research Agency (ANR), provides PhD students with a 3-year doctoral contract, mobility support, high-level training sessions and access to state-of-the-art research platforms, as well as possibilities to travel abroad to learn new techniques. The...
RHU DELIVER – Press Release
Press ReleaseStrasbourg, December 13th, 2021THE DELIVER PROGRAM FOR LIVER DISEASE THERAPEUTIC INNOVATION IS LAUREATE OF THE 5TH CALL FOR UNIVERSITY-HOSPITAL RESEARCH PROJECTS IN HEALTH (RHU)The DELIVER project led by Prof. Thomas BAUMERT is among the 17 winners - out of a total 89 candidates - of the 5th call for...
Dr. Crouchet ON AIR ! – Interview at RCF
Dr. Émilie Crouchet aux micros de RCF Radio: Un modèle d'étude cellulaire contre la "maladie du foie gras" Émilie Crouchet - © RCF Alsace Nos habitudes alimentaires, et surtout nos excès en gras, sucré, salé et alcool provoquent chaque année de nombreuses maladies du foie, des cirrhoses par exemple mais...
Dr. Crouchet in Nature Communications
Our latest research on "New Therapeutic Strategies for Chronic Liver Diseases and Liver Cancer" has just been published on Nature Communications. Find here the official press release. Click Here
ANR 2021 – DELTArget project awarded
Dr. Eloi Verrier's DELTArget program is laureate of the ANR JCJC 2021 Eloi Verrier, research scientist at Inserm Unit U1110, will coordinate the ANR JCJC Project DELTArget adressing the characterization of liver host factors involved in hepatitis D virus infection for the identification of novel therapeutic targetsDifferent research positions will...
Dr. Ligat – «Best of ILC» 2021
Dr. Gaetan Ligat's abstract selected for the "Best of ILC" International Liver Congress™ 2021, 23–26 June Our abstract, Ligat G, et al. ILC 2021; 175, entitled « A cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral target » has been selected for inclusion...
ERC AdG 2020 – Prof. Baumert awarded
ERC Advanced Grants 2020 : Thomas Baumert lauréat pour ses recherches sur la fibrose et le cancer du foie Le professeur Thomas Baumert (Inserm/Université de Strasbourg/Hôpitaux Universitaires de Strasbourg) est lauréat, pour la seconde fois, du prestigieux financement européen ERC Advanced Grant* pour son programme de recherche visant à identifier...
American Association of Physicians
Prof. Thomas Baumert elected foreign member of the American Association of Physicians Following the nomination of Dr. T. Jake Liang, Chief of the US NIH Liver Disease Branch, Pr. Thomas Baumert has been elected as foreign member of the American Association of Physicians (AAP). "Thomas, Welcome to the AAP and you...